StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.29−0.01 (-0.23%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Precigen cash

Cash and short-term investments held at the end of each period.

Precigen's cash was $38.70M at Jun 30, 2026. For fiscal 2025 it was $100.37M, up 2.5% from the year before. Over ten years it grew -8.3% a year on average. The highest annual figure on record is $244.20M in fiscal 2016.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$100.37M+2.5%
FY2024Dec 31, 2024$97.91M+55.7%
FY2023Dec 31, 2023$62.90M-36.9%
FY2022Dec 31, 2022$99.69M-13.8%
FY2021Dec 31, 2021$115.58M+14.9%
FY2020Dec 31, 2020$100.58M+29.5%
FY2019Dec 31, 2019$77.69M-65.1%
FY2018Dec 31, 2018$222.46M+171.9%
FY2017Dec 31, 2017$81.82M-66.5%
FY2016Dec 31, 2016$244.20M+2.5%
FY2015Dec 31, 2015$238.31M+105.5%
FY2014Dec 31, 2014$115.96M-34.7%
FY2013Dec 31, 2013$177.49M+1564.5%
FY2012Dec 31, 2012$10.66M-45.7%
FY2011Dec 31, 2011$19.63M+13.0%
FY2010Dec 31, 2010$17.37M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$38.70M-35.2%
Q1 FY2026Mar 31, 2026$56.74M-29.9%
Q4 FY2025Dec 31, 2025$100.37M+2.5%
Q3 FY2025Sep 30, 2025$123.64M+331.9%
Q2 FY2025Jun 30, 2025$59.75M+205.9%
Q1 FY2025Mar 31, 2025$80.99M+81.0%
Q4 FY2024Dec 31, 2024$97.91M+55.7%
Q3 FY2024Sep 30, 2024$28.63M-61.3%
Q2 FY2024Jun 30, 2024$19.54M-78.0%
Q1 FY2024Mar 31, 2024$44.76M-62.2%
Q4 FY2023Dec 31, 2023$62.90M-36.9%
Q3 FY2023Sep 30, 2023$74.01M-52.0%
Q2 FY2023Jun 30, 2023$88.84M-26.8%
Q1 FY2023Mar 31, 2023$118.30M+5.1%
Q4 FY2022Dec 31, 2022$99.69M-13.8%
Q3 FY2022Sep 30, 2022$154.14M+34.2%
Q2 FY2022Jun 30, 2022$121.35M+5.0%
Q1 FY2022Mar 31, 2022$112.56M+6.1%
Q4 FY2021Dec 31, 2021$115.58M+14.9%
Q3 FY2021Sep 30, 2021$114.84M+1.2%
Q2 FY2021Jun 30, 2021$115.55M-13.4%
Q1 FY2021Mar 31, 2021$106.12M-29.1%
Q4 FY2020Dec 31, 2020$100.58M+29.5%
Q3 FY2020Sep 30, 2020$113.54M+26.6%
Q2 FY2020Jun 30, 2020$133.42M+6.1%
Q1 FY2020Mar 31, 2020$149.58M-17.6%
Q4 FY2019Dec 31, 2019$77.69M-65.1%
Q3 FY2019Sep 30, 2019$89.71M-64.7%
Q2 FY2019Jun 30, 2019$125.80M+45.9%
Q1 FY2019Mar 31, 2019$181.63M+42.3%
Q4 FY2018Dec 31, 2018$222.46M+171.9%
Q3 FY2018Sep 30, 2018$254.00M+118.7%
Q2 FY2018Jun 30, 2018$86.25M-47.6%
Q1 FY2018Mar 31, 2018$127.65M-39.8%
Q4 FY2017Dec 31, 2017$81.82M-66.5%
Q3 FY2017Sep 30, 2017$116.15M-50.9%
Q2 FY2017Jun 30, 2017$164.58M–
Q1 FY2017Mar 31, 2017$212.22M–
Q4 FY2016Dec 31, 2016$244.20M–
Q3 FY2016Sep 30, 2016$236.55M–

More Precigen figures

See a number that looks wrong?